Adhesion Molecule Expression in Fibroblasts: Alteration in Fibroblast Biology After Transfection With LOX-1 Plasmids

The endothelial lectinlike, oxidatively (ox-) modified LDL receptor LOX-1 is a critical player in the pathogenesis of atherosclerosis and myocardial ischemia. Ox-LDL binding of LOX-1 results in the expression of various adhesion molecules, which attract monocytes to endothelial cells, an initial step in atherogenesis. We wished to examine the role of the ox-LDL/LOX-1 signaling pathway in fibroblasts, which naturally express low levels of LOX-1. Rat cardiac fibroblasts were transfected with either cytomegalovirus (CMV)-LOX-1wt (amino acids [aa] 1 to 273) or CMV-LOX-11-261 (an ox-LDL–binding negative mutant, aa 1 to 261) plasmid. Western blots showed that LOX-1 protein expression was increased significantly in cells transfected with CMV-LOX-1wt or CMV-LOX-11-261 plasmid (P<0.01 vs control). Fibroblasts transfected with CMV-LOX-1wt showed ox-LDL binding, whereas fibroblasts without transfection and those transfected with CMV-LOX-11-261 did not bind ox-LDL. Compared with untransfected cells, ox-LDL treatment (50 &mgr;g/mL, 24 hours) markedly induced the expression of the leukocyte adhesion molecules intercellular adhesion molecule-1 (ICAM-1), and vascular cell adhesion molecule-1 (VCAM)-1 as well as matrix metalloproteinase (MMP)-1 in cells transfected with CMV-LOX-1wt (P<0.05) but not in cells transfected with CMV-LOX-11-261. Concurrently, ox-LDL treatment enhanced the phosphorylation of p38 mitogen-activated protein kinase (MAPK) (P<0.05 vs control) in CMV-LOX-1wt–transfected cells. These data suggest that in cardiac fibroblasts, ox-LDL binds to LOX-1 and activates p38 MAPK, followed by the expression of ICAM-1, VCAM-1, and MMP-1. Thus, fibroblasts transform into an endothelial phenotype on transfection with CMV-LOX-1wt and subsequent exposure to ox-LDL. This study provides a useful model system (plasmid-transfected fibroblasts) to study the molecular biology of LOX-1.

[1]  J. Mehta,et al.  Anoxia-Reoxygenation Stimulates Collagen Type-I and MMP-1 Expression in Cardiac Fibroblasts: Modulation by the PPAR-γ Ligand Pioglitazone , 2004, Journal of cardiovascular pharmacology.

[2]  J. Mehta,et al.  Angiotensin II Regulation of Collagen Type I Expression in Cardiac Fibroblasts: Modulation by PPAR-&ggr; Ligand Pioglitazone , 2004, Hypertension.

[3]  J. Saklatvala.  The p38 MAP kinase pathway as a therapeutic target in inflammatory disease. , 2004, Current opinion in pharmacology.

[4]  C. Wainwright.  Matrix metalloproteinases, oxidative stress and the acute response to acute myocardial ischaemia and reperfusion. , 2004, Current opinion in pharmacology.

[5]  N. Otori,et al.  TNF‐α and IL‐4 regulate expression of fractalkine (CX3CL1) as a membrane‐anchored proadhesive protein and soluble chemotactic peptide on human fibroblasts , 2004, FEBS letters.

[6]  J. Mehta,et al.  Pioglitazone Inhibits LOX-1 Expression in Human Coronary Artery Endothelial Cells by Reducing Intracellular Superoxide Radical Generation , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[7]  J. Paramo,et al.  Different expression of MMPs/TIMP-1 in human atherosclerotic lesions. Relation to plaque features and vascular bed. , 2003, Atherosclerosis.

[8]  J. Mehta,et al.  EPA and DHA attenuate ox-LDL-induced expression of adhesion molecules in human coronary artery endothelial cells via protein kinase B pathway. , 2003, Journal of molecular and cellular cardiology.

[9]  J. Mehta,et al.  Eicosapentanoic acid inhibits hypoxia-reoxygenation-induced injury by attenuating upregulation of MMP-1 in adult rat myocytes. , 2003, Cardiovascular research.

[10]  J. Mehta,et al.  Expression of lectin-like oxidized low-density lipoprotein receptors during ischemia-reperfusion and its role in determination of apoptosis and left ventricular dysfunction. , 2003, Journal of the American College of Cardiology.

[11]  J. Mehta,et al.  LOX-1 Mediates Oxidized Low-Density Lipoprotein-Induced Expression of Matrix Metalloproteinases in Human Coronary Artery Endothelial Cells , 2003, Circulation.

[12]  D. Li,et al.  Oxidized Low-Density Lipoprotein Receptor LOX-1 and Apoptosis in Human Atherosclerotic Lesions , 2002, Journal of cardiovascular pharmacology and therapeutics.

[13]  Z. Galis,et al.  This Review Is Part of a Thematic Series on Matrix Metalloproteinases, Which Includes the following Articles: Matrix Metalloproteinase Inhibition after Myocardial Infarction: a New Approach to Prevent Heart Failure? Matrix Metalloproteinases in Vascular Remodeling and Atherogenesis: the Good, the Ba , 2022 .

[14]  S. Narumiya,et al.  Diabetes enhances lectin-like oxidized LDL receptor-1 (LOX-1) expression in the vascular endothelium: possible role of LOX-1 ligand and AGE. , 2001, Biochemical and biophysical research communications.

[15]  T. Sawamura,et al.  Conserved C-terminal residues within the lectin-like domain of LOX-1 are essential for oxidized low-density-lipoprotein binding. , 2001, The Biochemical journal.

[16]  T. Kita,et al.  Increased expression of lectin-like oxidized low density lipoprotein receptor-1 in initial atherosclerotic lesions of Watanabe heritable hyperlipidemic rabbits. , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[17]  Rongsong Li,et al.  Basigin (murine EMMPRIN) stimulates matrix metalloproteinase production by fibroblasts , 2001, Journal of cellular physiology.

[18]  T. V. van Berkel,et al.  Hepatic and extrahepatic scavenger receptors: function in relation to disease. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[19]  J. Mehta,et al.  Antisense to LOX-1 inhibits oxidized LDL-mediated upregulation of monocyte chemoattractant protein-1 and monocyte adhesion to human coronary artery endothelial cells. , 2000, Circulation.

[20]  F. Spinale,et al.  Myocardial matrix degradation and metalloproteinase activation in the failing heart: a potential therapeutic target. , 2000, Cardiovascular research.

[21]  S. Narumiya,et al.  Increased Expression of Lectinlike Oxidized Low Density Lipoprotein Receptor-1 in Initial Atherosclerotic Lesions of Watanabe Heritable Hyperlipidemic Rabbits , 2000 .

[22]  J. Swantek,et al.  New insights into the control of MAP kinase pathways. , 1999, Experimental Cell Research.

[23]  B. Kim,et al.  LDL stimulates collagen mRNA synthesis in mesangial cells through induction of PKC and TGF-beta expression. , 1999, American Journal of Physiology.

[24]  Hyun Soon Lee,et al.  LDL stimulates collagen mRNA synthesis in mesangial cells through induction of PKC and TGF-β expression. , 1999, American journal of physiology. Renal physiology.

[25]  S. Miyamoto,et al.  Expression of lectinlike oxidized low-density lipoprotein receptor-1 in human atherosclerotic lesions. , 1999, Circulation.

[26]  K. Williams,et al.  Atherosclerosis--an inflammatory disease. , 1999, The New England journal of medicine.

[27]  T. Kita.  LOX-1, a possible clue to the missing link between hypertension and atherogenesis. , 1999, Circulation research.

[28]  J. G. Kim,et al.  Demonstration of the presence of lipid peroxide-modified proteins in human atherosclerotic lesions using a novel lipid peroxide-modified anti-peptide antibody. , 1999, Atherosclerosis.

[29]  M. R. Roach,et al.  Local changes in collagen content in rabbit aortic atherosclerotic lesions with time. , 1999, Atherosclerosis.

[30]  R. Lorenz,et al.  The expression of the lectin-like oxidized low-density lipoprotein receptor (LOX-1) on human vascular smooth muscle cells and monocytes and its down-regulation by lovastatin. , 1999, Biochemical pharmacology.

[31]  U. Steinbrecher.  Receptors for oxidized low density lipoprotein. , 1999, Biochimica et biophysica acta.

[32]  T. Kita,et al.  Expression of lectin‐like oxidized low density lipoprotein receptor‐1 in human and murine macrophages: upregulated expression by TNF‐α , 1998, FEBS letters.

[33]  D. Steinberg,et al.  Identification of the lectin-like receptor for oxidized low-density lipoprotein in human macrophages and its potential role as a scavenger receptor. , 1998, The Biochemical journal.

[34]  C. Long,et al.  Expression and regulation of adhesion molecules in cardiac cells by cytokines: response to acute hypoxia. , 1998, Circulation research.

[35]  K. Weber,et al.  Extracellular matrix remodeling in heart failure: a role for de novo angiotensin II generation. , 1997, Circulation.

[36]  T. Sawamura,et al.  Enhanced expression of endothelial oxidized low-density lipoprotein receptor (LOX-1) in hypertensive rats. , 1997, Biochemical and biophysical research communications.

[37]  Daniel Steinberg,et al.  Low Density Lipoprotein Oxidation and Its Pathobiological Significance* , 1997, The Journal of Biological Chemistry.

[38]  T. Kita,et al.  An endothelial receptor for oxidized low-density lipoprotein , 1997, Nature.

[39]  M. Freeman.  Scavenger receptors in atherosclerosis , 1997, Current opinion in hematology.